Description
Sports medicines are known as the branch of medicines that deals with the physical health and curing or prevention of sports relates injuries. In almost a last decade it has been noticed that people are more aware about health. Increasing health education in school and different programs on social media has led to increase the awareness about health. People have started adopting sports as the mean to maintain the health and as extracurricular activity. Not only young but elderly people have also adopted sports. This has led to increase the number of sports related injuries across the globe.
Notably, rising prevalence of sports injuries is the key factor driving the sports medicine market. According to US centers for diseases control, around 10 % of kids and teen participating in the sports suffer from minor or major type of injury. Majority of the sports injury occur during 12-16 yr. age.
Other push factors such as, increasing number of sports medicine associations, increasing awareness, and technological development are also propelling the growth of the market. Increasing awareness is the most important part in development of the healthcare sector. Increase in the sports and health related education amongst the people has encourage to play different sports. Many aged people started participating in the different sports. Knowledge about enhancing health, risk of diseases and various advantages of playing sports has encourage people to play different sports.
The global sports medicines market is expected to reach USD 9,655.6 million by 2023 at a CAGR of 8.9% during the forecast period.
On the basis of products, market is segmented into joint reconstructive & repair products, support & recovery products, accessories & consumables, and others. The joint reconstructive & repair products segment accounted for the largest market share of 40% during the forecast period.
On the basis of application, market is segmented into shoulder treatment, knee treatment, hip treatment, spine treatment, others. Knee treatment market is expected to grow at a CAGR of 9.3% from 2016 to 2023.
On the basis of regions, the market is segmented into Americas, Europe, Asia-Pacific and the Middle East & Africa. Americas captured a largest market share of around 39.2% in 2016 globally. The shoulder treatment market for North America was estimated at USD 562.8 Million in 2016 and is expected to reach at USD 1,055.4 Million by 2023 at a CAGR of 8.9%.
Key Players
Medtronic, Stryker, Arthrex, Inc, Zimmer Biomet, Conmed Corporation, DePuy Synthes, GE Healthcare, and Smith & Nephew plc.
Study objectives
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global sports medicines market
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on product, application, procedures, end user, and regions for the global sports medicines market.
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influences the global sports medicines market
• To provide detailed analysis of the value chain and supply chain of the global sports medicines market
Target Audience
• Sports medicines manufacturers
• Sports medicines Suppliers
• Sports medicines Distributors
• Pharmaceutical companies
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic Medical Institutes and Universities
Key Findings
• Americas accounted for the largest market share in the global sports medicines market, USD 1,883.6 million in 2016 and expected to reach by USD 3,701.2 million by 2023 at a fastest CAGR of 8.6%
• Support & Recovery Product is the fastest growing segment with a CAGR of and 9.2% in the global sports medicines market, by product
• Ambulatory Care is growing at a CAGR of 9.3% in the global sports medicines market.
The reports also covers regional analysis
• Americas
o North America
US
Canada
o South America
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa
Table of Contents
1 Report Prologue 12
2 Introduction 18
2.1 Scope of Study 18
2.2 Research Objective 18
2.3 Assumptions & Limitations 18
2.3.1 Assumptions 18
2.3.2 Limitations 18
2.4 Market Structure 19
3 Research Methodology 20
3.1 Primary Research 21
3.2 Secondary Research 21
4 Market Dynamics 22
4.1 Drivers 22
4.1.1 Increasing prevalence of Sports Injuries 22
4.1.2 Increasing number of Sports Medicine Associations 23
4.1.3 Increasing Awareness 23
4.1.4 Technological development 23
4.2 Restraints 23
4.2.1 Lack of skilled professionals 23
4.2.2 High cost 23
4.3 Opportunities 24
4.3.1 Rise in influx of athletes 24
4.3.2 Technological advances in sports medicines 24
4.4 Threats 24
4.4.1 Introduction of small and medium sized companies 24
5 Market Factor Analysis 25
5.1 Porters Five Forces Analysis 25
5.1.1 Bargaining Power of Suppliers 26
5.1.2 Bargaining Power of Buyers 26
5.1.3 Threat of New Entrants 26
5.1.4 Threat of Substitutes 26
5.1.5 Intensity of Rivalry 27
6 Global Sports Medicine Market, By Product 28
6.1 Introduction 28
6.1.1 Joint Reconstructive & Repair Products 30
6.1.2 Body Support and recovery products 31
6.1.3 Accessories 32
7 Global Sports Medicines Market, By Application 33
7.1 Introduction 33
7.1.1 Shoulder Treatment 35
7.1.2 Knee Treatment 36
7.1.3 Hip Treatment 37
7.1.4 Spine Treatment 38
8 Global Sports Medicines Market, by Procedures 39
8.1 Introduction 39
8.1.1 Tendinosis 41
8.1.2 Tendon to Bone 42
8.1.3 Cartilage repair 43
9 Global Sports Medicines Market, By End User 44
9.1 Introduction 44
9.1.1 Hospital & Emergency Care 45
9.1.2 Trauma center 47
9.1.3 Ambulatory Care 48
10 Global Sports Medicine Market, By Region 49
10.1 Introduction 49
10.2 North America 51
10.2.1 Introduction 51
10.2.2 U.S. 55
10.2.3 Canada 57
10.2.4 South America 59
10.3 Europe 62
10.3.1 Introduction 62
10.3.2 Germany 66
10.3.3 France 68
10.3.4 U.K. 70
10.3.5 Italy 72
10.3.6 Spain 74
10.3.7 Rest of Western Europe 76
10.3.8 Eastern Europe 78
10.4 Asia-Pacific 81
10.4.1 Introduction 81
10.4.2 Japan 84
10.4.3 China 86
10.4.4 India 88
10.4.5 Republic of Korea 90
10.4.6 Australia 92
10.4.7 Rest of Asia Pacific 94
10.5 Middle East & Africa 97
10.5.1 Introduction 97
10.5.2 Middle East 100
10.5.3 Africa 102
11 Company Landscape 104
11.1 Introduction 104
12 Company Profile 107
12.1 Medtronics 107
12.1.1 Company Overview 107
12.1.2 Product/Business Segment Overview 107
12.1.3 Financial Overview 108
12.1.4 Key Development 109
12.2 Stryker 110
12.2.1 Company Overview 110
12.2.2 Product/Business Segment Overview 110
12.2.3 Financial Overview 111
12.2.4 Key Development 112
12.3 Zimmer Biomet 113
12.3.1 Company Overview 113
12.3.2 Product/Business Segment Overview 113
12.3.3 Financial Overview 114
12.3.4 Key Development 115
12.4 Conmed Corporation 116
12.4.1 Company Overview 116
12.4.2 Product/Business Segment Overview 116
12.4.3 Financial Overview 117
12.4.4 Key Development 118
12.5 DePuy Synthes 119
12.5.1 Company Overview 119
12.5.2 Product/Business Segment Overview 119
12.5.3 Financial Overview 120
12.5.4 Key Development 121
12.6 GE Healthcare 122
12.6.1 Company Overview 122
12.6.2 Product/Business Segment Overview 122
12.6.3 Financial Overview 123
12.6.4 Key Development 124
12.7 Smith & Nephew plc 125
12.7.1 Company Overview 125
12.7.2 Product Overview 125
12.7.3 Financials 126
12.7.4 Key Developments 127
12.8 Arthrex, Inc. 128
12.8.1 Company Overview 128
12.8.2 Product/Business Segment Overview 128
12.8.3 Financial Overview 129
12.8.4 Key Development 129
1 Report Prologue 122 Introduction 182.1 Scope of Study 182.2 Research Objective 182.3 Assumptions & Limitations 182.3.1 Assumptions 182.3.2 Limitations 182.4 Market Structure 193 Research Methodology 203.1 Primary Research 213.2 Secondary Research 214 Market Dynamics 224.1 Drivers 224.1.1 Increasing prevalence of Sports Injuries 224.1.2 Increasing number of Sports Medicine Associations 234.1.3 Increasing Awareness 234.1.4 Technological development 234.2 Restraints 234.2.1 Lack of skilled professionals 234.2.2 High cost 234.3 Opportunities 244.3.1 Rise in influx of athletes 244.3.2 Technological advances in sports medicines 244.4 Threats 244.4.1 Introduction of small and medium sized companies 245 Market Factor Analysis 255.1 Porters Five Forces Analysis 255.1.1 Bargaining Power of Suppliers 265.1.2 Bargaining Power of Buyers 265.1.3 Threat of New Entrants 265.1.4 Threat of Substitutes 265.1.5 Intensity of Rivalry 276 Global Sports Medicine Market, By Product 286.1 Introduction 286.1.1 Joint Reconstructive & Repair Products 306.1.2 Body Support and recovery products 316.1.3 Accessories 327 Global Sports Medicines Market, By Application 337.1 Introduction 337.1.1 Shoulder Treatment 357.1.2 Knee Treatment 367.1.3 Hip Treatment 377.1.4 Spine Treatment 388 Global Sports Medicines Market, by Procedures 398.1 Introduction 398.1.1 Tendinosis 418.1.2 Tendon to Bone 428.1.3 Cartilage repair 439 Global Sports Medicines Market, By End User 449.1 Introduction 449.1.1 Hospital & Emergency Care 459.1.2 Trauma center 479.1.3 Ambulatory Care 4810 Global Sports Medicine Market, By Region 4910.1 Introduction 4910.2 North America 5110.2.1 Introduction 5110.2.2 U.S. 5510.2.3 Canada 5710.2.4 South America 5910.3 Europe 6210.3.1 Introduction 6210.3.2 Germany 6610.3.3 France 6810.3.4 U.K. 7010.3.5 Italy 7210.3.6 Spain 7410.3.7 Rest of Western Europe 7610.3.8 Eastern Europe 7810.4 Asia-Pacific 8110.4.1 Introduction 8110.4.2 Japan 8410.4.3 China 8610.4.4 India 8810.4.5 Republic of Korea 9010.4.6 Australia 9210.4.7 Rest of Asia Pacific 9410.5 Middle East & Africa 9710.5.1 Introduction 9710.5.2 Middle East 10010.5.3 Africa 10211 Company Landscape 10411.1 Introduction 10412 Company Profile 10712.1 Medtronics 10712.1.1 Company Overview 10712.1.2 Product/Business Segment Overview 10712.1.3 Financial Overview 10812.1.4 Key Development 10912.2 Stryker 11012.2.1 Company Overview 11012.2.2 Product/Business Segment Overview 11012.2.3 Financial Overview 11112.2.4 Key Development 11212.3 Zimmer Biomet 11312.3.1 Company Overview 11312.3.2 Product/Business Segment Overview 11312.3.3 Financial Overview 11412.3.4 Key Development 11512.4 Conmed Corporation 11612.4.1 Company Overview 11612.4.2 Product/Business Segment Overview 11612.4.3 Financial Overview 11712.4.4 Key Development 11812.5 DePuy Synthes 11912.5.1 Company Overview 11912.5.2 Product/Business Segment Overview 11912.5.3 Financial Overview 12012.5.4 Key Development 12112.6 GE Healthcare 12212.6.1 Company Overview 12212.6.2 Product/Business Segment Overview 12212.6.3 Financial Overview 12312.6.4 Key Development 12412.7 Smith & Nephew plc 12512.7.1 Company Overview 12512.7.2 Product Overview 12512.7.3 Financials 12612.7.4 Key Developments 12712.8 Arthrex, Inc. 12812.8.1 Company Overview 12812.8.2 Product/Business Segment Overview 12812.8.3 Financial Overview 12912.8.4 Key Development 129
